missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18128136

RARRES1 Antibody (OTI1D2), Biotin, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-73803B

Product Code. 18128136

  • ONLINE EXCLUSIVE PRICE
    € 807.00
    € 763.35 / 0.10mL
    Save € 43.65
    5% Off

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

RARRES1 Monoclonal specifically detects RARRES1 in Human, Mouse, Rat, Canine, Monkey samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

RARRES1
Monoclonal
Biotin
PBS with 0.05% Sodium Azide
RARRES1
Full length recombinant protein of human RARRES1 (NP_996846) produced in HEK293T cells.
0.1 mL
Primary
Human, Mouse, Rat, Canine, Monkey
IgG2b
Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence
OTI1D2
Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence
RAR-responsive protein TIG1, retinoic acid receptor responder (tazarotene induced) 1, retinoic acid receptor responder protein 1, TIG1Tazarotene-induced gene 1 protein
Mouse
Affinity Purified
Cell Cycle and Replication
5918.0
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.